Journal of Skin and Stem Cell

Published by: Kowsar

Autoimmune Thyroid Disorders in Patients With Vitiligo

Abbas Zamanian 1 , Pezhman Mobasher 2 , * , Akram Ansar 2 , Shaghayegh Manuchehri 2 and Ghazaleh Ahmadi Jazi 2
Authors Information
1 Department of Dermatology, Iran University of Medical Sciences, Tehran, Iran
2 Skin and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran, Iran
Article information
  • Journal of Skin and Stem Cell: October 1, 2014, 1 (2); e22113
  • Published Online: October 7, 2014
  • Article Type: Research Article
  • Received: July 16, 2014
  • Revised: September 6, 2014
  • Accepted: September 7, 2014
  • DOI: 10.17795/jssc22113

To Cite: Zamanian A, Mobasher P, Ansar A, Manuchehri S, Ahmadi Jazi G. Autoimmune Thyroid Disorders in Patients With Vitiligo, J Skin Stem Cell. 2014 ; 1(2):e22113. doi: 10.17795/jssc22113.

Abstract
Copyright © 2014, Skin and Stem Cell Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Footnote
References
  • 1. Bolognia JL, Jorrizo JL, Rapini RP. Dermatology. 2008;
  • 2. Das SK, Majumder PP, Chakraborty R, Majumdar TK, Haldar B. Studies on vitiligo. I. Epidemiological profile in Calcutta, India. Genet Epidemiol. 1985; 2(1): 71-8[DOI][PubMed]
  • 3. Zamanian M, Azimian M. [prevalence of vitiligo in rural areas of Hamedan (Iran)in 2006]. Ir J dermatol. 2005; 5(1): 379-82
  • 4. Halioua B, Beumont MG, Lunel F. Quality of life in dermatology. Int J Dermatol. 2000; 39(11): 801-6[PubMed]
  • 5. Porter J. Personal Responses of Patients to Vitiligo. Arch Dermatol. 1978; 114(9): 1384[DOI]
  • 6. Jayaprakasam A, Darvay A, Osborne G, McGibbon D. Comparison of assessments of severity and quality of life in cutaneous disease. Clin Exp Dermatol. 2002; 27(4): 306-8[PubMed]
  • 7. Harlow D, Poyner T, Finlay AY, Dykes PJ. Impaired quality of life of adults with skin disease in primary care. Br J Dermatol. 2000; 143(5): 979-82[PubMed]
  • 8. Ravinder K, Daivinder P. Melanocytophagy and apoptosis in vitilligo. Indian J Dermatol Venereol. 2012; 78(1): 10-23
  • 9. James WD, Berge rTG, Elston DM. Andrew's Diseases Of The Skin. 2006;
  • 10. Iacovelli P, Sinagra JL, Vidolin AP, Marenda S, Capitanio B, Leone G, et al. Relevance of thyroiditis and of other autoimmune diseases in children with vitiligo. Dermatology. 2005; 210(1): 26-30[DOI][PubMed]
  • 11. Dave S,, D'souza M, Thapp DM. High frequency of thyroid dysfunction in Indian patients with vitiligo. Indian J Dermatol. 2003; : 48-68
  • 12. Daneshpazhooh M, Mostofizadeh GM, Behjati J, Akhyani M, Robati RM. Anti-thyroid peroxidase antibody and vitiligo: a controlled study. BMC Dermatol. 2006; 6: 3[DOI][PubMed]
  • 13. Manighalam SH, Haji Abdolhamid M, Tousi P. association between vitiligoan thyroid dysfunction. Ir J Endocrinol Metab. 2002; 3(1): 165-8
  • 14. Vanderpump MPJ, Tunbridge WMG. The epidemiology of thyroid disease. The thyroid a fundamental and clinical text. 2000; : 487-73
  • 15. Arycan O, Koc K, Ersoy L. Clinical characteristics in 113 Turkish vitiligo patients. Acta Dermatovenerol Alp Pannonica Adriat. 2008; 17(3): 129-32[PubMed]
  • 16. Birlea SA, Fain PR, Spritz RA. A Romanian population isolate with high frequency of vitiligo and associated autoimmune diseases. Arch Dermatol. 2008; 144(3): 310-6[PubMed]
  • 17. Fernandes NC, Campos MM. Childhood vitiligo and thyroid disease. An Bras Dermatol. 2009; 84(2): 200-2[PubMed]
  • 18. Moradi S, Ghafarpoor G. Thyroid dysfunction and thyroid antibodies in Iranian patients with vitiligo. Indian J Dermatol. 2008; 53(1): 9-11[DOI][PubMed]
  • 19. Behl PN, Aggarwal A, Srivastava G. Practice of Dermatology. 2003; : 238-41
  • 20. Herane MI. Vitiligo and leukoderma in children. Clin Dermatol. 2003; 21(4): 283-95[PubMed]
  • 21. Jaigirdar MQ, Alam SM, Maidul AZ. Clinical presentation of vitiligo. Mymensingh Med J. 2002; 11(2): 79-81[PubMed]
  • 22. Engel L. What are those white patches on my patient's skin? Dermatol Nurs. 2001; 13(4): 292-7[PubMed]
  • 23. Lerner MR, Fitzpatrick TB, Halder RM, Hawk JL. Discussion of a case of vitiligo. Photodermatol Photoimmunol Photomed. 1999; 15(1): 41-4[PubMed]
  • 24. Nordlund JJ, Lerner AB. Vitiligo. It is important. Arch Dermatol. 1982; 118(1): 5-8[PubMed]
  • 25. Kumar V, Shankar V, Chaudhary S, Bhatia KK, Mehta LK, Arora N, et al. Radio-active iodine uptake in vitiligo. J Dermatol. 1990; 17(1): 41-3[PubMed]
  • 26. Hegedus L, Heidenheim M, Gervil M, Hjalgrim H, Hoier-Madsen M. High frequency of thyroid dysfunction in patients with vitiligo. Acta Derm Venereol. 1994; 74(2): 120-3[PubMed]
  • 27. Zettinig G, Tanew A, Fischer G, Mayr W, Dudczak R, Weissel M. Autoimmune diseases in vitiligo: do anti-nuclear antibodies decrease thyroid volume? Clin Exp Immunol. 2003; 131(2): 347-54[PubMed]
  • 28. Majumder PP, Nordlund JJ, Nath SK. Pattern of familial aggregation of vitiligo. Arch Dermatol. 1993; 129(8): 994-8[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments